We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

159 hedge funds and large institutions have $603M invested in Collegium Pharmaceutical in 2020 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 48 increasing their positions, 50 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 21

24% more call options, than puts

Call options by funds: $1.47M | Put options by funds: $1.19M

15% more funds holding

Funds holding: 138 → 159 (+21)

13.88% more ownership

Funds ownership: 93.98% → 107.86% (+14%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 50

7% less capital invested

Capital invested by funds: $649M → $603M (-$45.2M)

Holders
159
Holders Change
+21
Holders Change %
+15.22%
% of All Funds
3.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
44
Increased
48
Reduced
50
Closed
21
Calls
$1.47M
Puts
$1.19M
Net Calls
+$282K
Net Calls Change
-$744K

Top Buyers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
+$41.3M
2
RCMNY
Rubric Capital Management (New York)
New York
+$25M
3
PA
Perceptive Advisors
New York
+$23.3M
4
Invesco
Invesco
Georgia
+$14M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$12.4M

Top Sellers

Rank Fund Capital Flow
1
FM
Frazier Management
Washington
-$19.5M
2
RSCM
Rock Springs Capital Management
Maryland
-$8.26M
3
SAM
Sectoral Asset Management
Quebec, Canada
-$6.47M
4
PAM
Panagora Asset Management
Massachusetts
-$3.76M
5
APM
Avidity Partners Management
Texas
-$3.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
SEI Investments
76
SEI Investments
Pennsylvania
$639K +$810K +39,268 New
MSL
77
Mackay Shields LLC
New York
$637K -$2.03M -98,500 -72%
1CM
78
1492 Capital Management
Wisconsin
$637K +$805K +38,991 New
Los Angeles Capital Management
79
Los Angeles Capital Management
California
$610K +$771K +37,360 New
RG
80
Renaissance Group
Kentucky
$592K +$21.4K +1,037 +3%
Fisher Asset Management
81
Fisher Asset Management
Washington
$584K – – –
PCM
82
Prelude Capital Management
New York
$561K +$709K +34,335 New
Squarepoint
83
Squarepoint
New York
$552K -$713K -34,542 -51%
VRS
84
Virginia Retirement Systems
Virginia
$545K -$103K -5,000 -13%
Man Group
85
Man Group
United Kingdom
$530K +$669K +32,431 New
New York State Common Retirement Fund
86
New York State Common Retirement Fund
New York
$523K – – –
MAM
87
Martingale Asset Management
Massachusetts
$512K +$647K +31,337 New
SO
88
STRS Ohio
Ohio
$498K -$105K -5,100 -14%
AAMU
89
Amundi Asset Management US
Massachusetts
$498K – – –
NC
90
NBW Capital
Massachusetts
$491K -$31.6K -1,532 -5%
Susquehanna International Group
91
Susquehanna International Group
Pennsylvania
$490K +$619K +30,011 New
AFAS
92
Acorn Financial Advisory Services
Virginia
$484K -$36.5K -1,767 -6%
CS
93
Credit Suisse
Switzerland
$458K -$286K -13,841 -33%
EGM
94
Engineers Gate Manager
New York
$454K +$574K +27,824 New
MPAM
95
Monarch Partners Asset Management
Massachusetts
$448K +$566K +27,445 New
Deutsche Bank
96
Deutsche Bank
Germany
$440K -$2.18M -105,480 -80%
VFA
97
Values First Advisors
Tennessee
$398K -$315K -15,254 -39%
NAM
98
Nexpoint Asset Management
Texas
$387K -$256K -12,426 -34%
UBS Group
99
UBS Group
Switzerland
$372K -$568K -27,522 -55%
TA
100
Teton Advisors
New York
$358K – – –
2 3
4
5 6

COLL Hedge Fund Activity: Q1 2020 in Review

159 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q1 2020, worth a combined $603M — down 7% from $649M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new COLL positions and 21 closed out — a net gain of 23 holders — while 48 added to existing stakes and 50 trimmed.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $41.3M. The largest seller was Frazier Management, cutting an estimated $19.5M.

  • 159 institutional investors held Collegium Pharmaceutical (COLL) as of Q1 2020, up from 138 in Q4 2019.
  • Funds reported $603M of Collegium Pharmaceutical stock for Q1 2020, down 7% quarter-over-quarter.
  • 44 funds opened new Collegium Pharmaceutical positions in Q1 2020 and 21 closed out, a net change of +23 holders.
  • The largest Collegium Pharmaceutical buyer in Q1 2020 was Camber Capital Management, an estimated $41.3M added.
  • The largest Collegium Pharmaceutical seller in Q1 2020 was Frazier Management, an estimated $19.5M sold.

Based on aggregated 13F filings for Q1 2020.